Physician profile
Michael Degon
NPI 1619100856
$1,318.65
in general payments reported to CMS, 2019-2025
21 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $17.09 · 2021: $3.82 · 2023: $360 · 2024: $421 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $262.02 | 2023 | |
| Coloplast Corp | $209.28 | 2019-2025 | |
| Janssen Biotech, INC. | $134.89 | 2023-2025 | Erleada |
| Endo USA, INC. | $124.46 | 2024 | Xiaflex |
| Pfizer INC. | $122.01 | 2024-2025 | |
| Boston Scientific Corporation | $53.06 | 2023 | Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $50.80 | 2024 | Xtandi |
| Angiodynamics, INC. | $50.32 | 2024 | Nanoknife |
| Procept Biorobotics Corporation | $42.42 | 2024 | Aquabeam System |
| Aveo Pharmaceuticals, INC. | $36.25 | 2024 | |
| Myriad Genetic Laboratories, INC. | $30.17 | 2025 | Prolaris |
| Cook Medical LLC | $28.20 | 2024 | Ncircle |
| Neotract INC. | $27.88 | 2019 | |
| Olympus America INC. | $26.73 | 2023-2025 | Uropass, Cysto-Nephro Videoscope, Itind System |
| Merck Sharp & Dohme LLC | $24.12 | 2025 | Keytruda |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $20.21 | 2019 | |
| Eisai INC. | $18.74 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.46 | 2024 | |
| Sumitomo Pharma America, INC. | $17.84 | 2025 | Orgovyx |
| Fujifilm Healthcare Americas Corporation | $16.97 | 2023 | Arietta Precision |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Degon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.